同时性双侧乳腺癌保乳术后放疗技术和近期疗效分析

doi:10.3760/cma.j.issn.1004-4221.2019.09.009

Abstract
Figure/Table
References()
Related Citation (13)
Read Tracking
Download Tracking

Download: PDF (0 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS) Supporting Info

Abstract

Objective To investigate the dose characteristics and outcomes of a single isocenter bilateral tangential fields (IBTF) combined with intensity-modulated radiotherapy (IMRT) in bilateral breast radiotherapy (BBR). Methods Fourteen female patients with synchronous bilateral breast cancer (SBBC) after breast-conserving surgery (BCS) were enrolled in this study. All patients received BBR using IBTF combined with IMRT at a conventional (50Gy/25f) or hypofractionated (43.5Gy/15f) dose. For patients with invasive cancer,the additional tumor bed boost was given with sequential electron radiation or simultaneously photon IMRT. The coverage, uniformity and short-term clinical efficacy were evaluated. Results The number of the irradiation field was 8-11,including 4-7 intensity-modulated fields. The bilateral breast PTV dose coverage reached 95% in all plans. For the tumor bed, the mean dose coverage was (95.54±1.33)%(left) and (94.19±1.03)%(right) using photon, and (90.25±8.79)%(left) and (85.28±8.35)%(right) using electron. The average V20 of bilateral lungs was (16.69±3.90)%. The cardiac Dmean was 5.48 Gy. Three patients presented with grade Ⅱ acute skin toxicities. No ≥ grade Ⅱ pneumonitis was observed. No recurrence occurred with the median follow-up time of 30.1 months. Eleven patients showed excellent cosmetic results. Conclusion BBR using IBTF combined with IMRT is efficacious and safe for patients with SBBC after BCS.

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	Ma Mingwei
	Wang Shulian
	Miao Junjie
	Tang Yu
	Zhao Bo
	Qin Shirui
	Zhang Jianghu
	Qi Shunan
	Chen Siye
	Ma Yuchao
	Liu Xin
	Li Yexiong

Key words： Breast neoplasm/adjuvant radiotherapy Radiation technique Short-term efficacy

Received: 18 October 2018

Fund:

National Key Research and Development Project (2016YFC0904600);Scientific Research Seed Fund of Peking University First Hospital (2018SF043)

Corresponding Authors: Wang Shulian,Email:wsl20040118@yahoo.com;Tang Yu,Email:tangyu_cams@163.com

Cite this article:

Ma Mingwei,Wang Shulian,Miao Junjie et al. Isocenter bilateral tangential fields combined with intensity-modulated radiotherapy for synchronous bilateral whole breast irradiation[J]. Chinese Journal of Radiation Oncology, 2019, 28(9): 677-681.

URL:

http://journal12.magtechjournal.com/Jweb_fszlx/EN/10.3760/cma.j.issn.1004-4221.2019.09.009 OR http://journal12.magtechjournal.com/Jweb_fszlx/EN/Y2019/V28/I9/677

[1] Gogas J,Markopoulos C,Skandalakis P,et al. Bilateral breast cancer[J]. Am Surg,1993,59(4):733-735.
[2] Michowitz M,Noy S,Lazebnik N,et al. Bilateral breast cancer[J]. J Surg Oncol,1985,30(1):109-112.
[3] Jobsen JJ,van der Palen J,Ong F,et al. Synchronous,bilateral breast cancer:prognostic value and incidence[J]. Breast,2003,12(1):83-88. DOI:10.1016/S0960-9776(02)00278-3
[4] Mueller CB,Ames F. Bilateral carcinoma of the breast:frequency and mortality[J]. Can J Surg,1978,21(3):459-465.
[5] Darby S,McGale P,Correa C,et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death:meta-analysis of individual patient data for 10,801 women in 17 randomised trials[J]. Lancet,2011,378(?):1707-1716. DOI:10.1016/s0140-6736(11)61629-2.
[6] Gollamudi SV,Gelman RS,Peiro G,et al. Breast-conserving therapy for stage Ⅰ-Ⅱ synchronous bilateral breast carcinoma[J]. Cancer,1997,79(7):1362-1369.
[7] Heaton KM,Peoples GE,Singletary SE,et al. Feasibility of breast conservation therapy in metachronous or synchronous bilateral breast cancer[J]. Ann Surg Oncol,1999,6(1):102-108.
[8] Wadasadawala T,Visariya B,Sarin R,et al. Use of tomotherapy in treatment of synchronous bilateral breast cancer:dosimetric comparison study[J]. Br J Radiol,2015,88(1048):20140612. DOI:10.1259/bjr.20140612.
[9] Jimenez RB,Goma C,Nyamwanda J,et al. Intensity modulated proton therapy for postmastectomy radiation of bilateral implant reconstructed breasts:a treatment planning study[J]. Radiother Oncol,2013,107(2):213-217. DOI:10.1016/j.radonc.2013.03.028.
[10] 贺春钰,司马义力·买买提尼牙孜,韩有溪,等. 双侧整体化逆向调强放疗在双侧乳腺癌术后放疗中应用[J]. 中华实用诊断与治疗杂志,2016,30(5):488-489. DOI:10.13507/j.issn.1674-3474.2016.05.025.
[11] Jobsen JJ,van der Palen J,Ong F,et al. Bilateral breast cancer,synchronous and metachronous;differences and outcome[J]. Breast Cancer Res Treat,2015,153(2):277-283. DOI:10.1007/s10549-015-3538-5.
[12] Haviland JS,Owen JR,Dewar JA,et al. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer:10-year follow-up results of two randomised controlled trials[J]. Lancet Oncol,2013,14(11):1086-1094. DOI:10.1016/s1470-2045(13)70386-3.
[13] Whelan TJ,Pignol JP,Levine MN,et al. Long-term results of hypofractionated radiation therapy for breast cancer[J]. N Engl J Med,2010,362(3):513-520. DOI:10.1056/NEJMoa0906260.
[14] Smith BD,Bellon JR,Blitzblau R,et al. Radiation therapy for the whole breast:executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline[J]. Pract Radiat Oncol,2018,8(1):145-152. DOI:10.1016/j.prro.2018.01.012.
[15] 曹茜,王义海,韩有溪,等. 早期乳腺癌保乳术后大分割调强放疗与常规放疗的临床疗效比较[J]. 临床肿瘤学杂志,2018,23(2):150-154.